Paul Coleman

Paul Coleman PhD, has been an Associate at the University of Arizona (UA) McKnight Brain Institute since 2010 and a Research Professor at the UA Biodesign Institute since 2015. In 2007, Dr. Coleman was appointed Professor Emeritus at the University of Rochester Medical Center. Since 1988, Dr. Coleman has served as Editor-in-Chief for the journal Neurobiology of Aging and is currently Editor Emeritus and an Advisory Editor. Dr. Coleman received an AB in Psychology (magna cum laude) from Tufts University and a PhD in Physiology and Psychology from the University of Rochester. Following his PhD, Dr. Coleman was supported by the National Institute of Neurological Disorders and Stroke as a Special Fellow at Johns Hopkins School of Medicine.

Dr. Coleman has been a pioneering investigator of the pathologic basis of AD. His work has provided insight into how synaptic network loss and dysfunction are correlated with cognitive decline. His early work examined dynamic processes of synaptic plasticity. At Cold Spring Harbor Laboratory, he developed a method for profiling gene expression in single cells in vitro which he subsequently applied to the postmortem human brain using both mRNA and in situ hybridization methods. Dr. Coleman published one of the first studies profiling gene expression of single neurons in the Alzheimer versus normal human brain. Dr. Coleman is the recipient of numerous awards including the LEAD Award: Leadership and Excellence in Alzheimer’s disease from NIH/NIA in 1990 to 1999 (one of 12 ever given), an Honorary Professorship from the Jilin Medical College in Jilin China in 1988 and a Pioneer Award: from the National Alzheimer’s and Related Disorders Association (1999 – 2004).